As of 2026-07-17, AbbVie (ABBV) has an overall Buy technical signal, while Merck (MRK) reads Buy. Over the last six months ABBV returned +20.2% versus MRK at +16.6% (so ABBV has outperformed on price). These are automated technical readings for education, not financial advice.
| Metric | ABBV | MRK |
|---|---|---|
| Price | $254.49 | $127.50 |
| Daily change | +0.04% | -0.10% |
| Overall signal | Buy | Buy |
| Confidence | 73% | 39% |
| 6-month return | +20.2% | +16.6% |
| RSI (14) | 66 | 58 |
| MACD | Sell | Sell |
| Trend | Uptrend | Uptrend |
AbbVie full analysis · Merck full analysis · Interactive chart →
⚠️ Not financial advice. Automated technical information for education only; indicators are not proven to beat buy-and-hold. © 2026 DailyTechnicals.